Dervla O'MAlley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dervla O'MAlley has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Timothy G. Dinan
University College Cork
17 shared publications - John Francis Cryan
APC Microbiome Ireland, University College Cork, Ireland; Department of Anatomy and Neuroscience, University College Cork, Ireland
16 shared publications - Jenni Harvey
Division of Neuroscience, School of Medicine University of Dundee Dundee UK
7 shared publications - Mark George Rae
University College Cork
7 shared publications - Ken D. O'HAlloran
Department of Physiology University College Cork Cork Ireland
6 shared publications Maria M. Buckley
Department of Physiology, University College Cork, Cork, Ireland
6 shared publications
Latest Publications
- Open Access
- 30 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-21
Neuronal hyperexcitability in dystrophin-deficient mdx hippocampal neurons: the importance of interleukin-6 and GABAergic regulation
Duchenne Muscular Dystrophy (DMD) is a severe neuromuscular disorder arising from loss of the structural protein, dystrophin. It also often presents with cognitive deficits and susceptibility to epilepsy. Expressed in neurons of the hippocampus, dystrophin plays an important role in synapse formation, specifically the post-synaptic organisation of γ-aminobutyric acid A receptors (GABAARs). This study explored possible interactions between interleukin (IL)-6, which is elevated in DMD, and GABAAR signalling in cultured hippocampal neurons of dystrophic mdx mice. Immunofluorescent imaging revealed altered development of network connectivity that displayed similar characteristics to dystrophin-expressing neurons cultured in elevated levels of IL-6. Mdx neurons dependably exhibited spontaneous oscillations. Calcium (Ca2+) signalling was further modulated by exposure to agonists and antagonists of GABAA and GABABRs. IL-6-evoked Ca2+ responses were enhanced by muscimol, a GABAAR agonist, in wildtype (WT) and mdx neurons, whilst bicuculline, a GABAAR antagonist, only suppressed IL-6-evoked Ca2+activity in WT neurons. The GABABR agonist, baclofen, enhanced IL-6-evoked Ca2+ responses only in mdx neurons. Our findings support dysfunctional GABAergic signalling in hippocampal neurons that lack dystrophin, resulting in aberrant neuronal network excitability. The contribution of elevated levels of IL-6 further impact upon Ca2+ dyshomeostasis in dystrophic neurons and may underpin cognitive changes reported in dystrophinopathies.
- 30 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-21
Open AccessNeuronal hyperexcitability in dystrophin-deficient mdx hippocampal neurons: the importance of interleukin-6 and GABAergic regulation
Duchenne Muscular Dystrophy (DMD) is a severe neuromuscular disorder arising from loss of the structural protein, dystrophin. It also often presents with cognitive deficits and susceptibility to epilepsy. Expressed in neurons of the hippocampus, dystrophin plays an important role in synapse formation, specifically the post-synaptic organisation of γ-aminobutyric acid A receptors (GABAARs). This study explored possible interactions between interleukin (IL)-6, which is elevated in DMD, and GABAAR signalling in cultured hippocampal neurons of dystrophic mdx mice. Immunofluorescent imaging revealed altered development of network connectivity that displayed similar characteristics to dystrophin-expressing neurons cultured in elevated levels of IL-6. Mdx neurons dependably exhibited spontaneous oscillations. Calcium (Ca2+) signalling was further modulated by exposure to agonists and antagonists of GABAA and GABABRs. IL-6-evoked Ca2+ responses were enhanced by muscimol, a GABAAR agonist, in wildtype (WT) and mdx neurons, whilst bicuculline, a GABAAR antagonist, only suppressed IL-6-evoked Ca2+activity in WT neurons. The GABABR agonist, baclofen, enhanced IL-6-evoked Ca2+ responses only in mdx neurons. Our findings support dysfunctional GABAergic signalling in hippocampal neurons that lack dystrophin, resulting in aberrant neuronal network excitability. The contribution of elevated levels of IL-6 further impact upon Ca2+ dyshomeostasis in dystrophic neurons and may underpin cognitive changes reported in dystrophinopathies.
- Open Access
- 10 January 2025
- Published by Wiley in Experimental Physiology
- Vol. 110 (4) , 585-598
Astrocyte proliferation in the hippocampal dentate gyrus is suppressed across the lifespan of dystrophin‐deficient mdx mice
Absence of the structural protein, dystrophin, results in the neuromuscular disorder Duchenne Muscular Dystrophy (DMD). In addition to progressive skeletal muscle dysfunction, this multisystemic disorder can also result in cognitive deficits and behavioural changes that are likely to be consequences of dystrophin loss from central neurons and astrocytes. Dystrophin‐deficient mdx mice exhibit decreases in grey matter volume in the hippocampus, the brain region that encodes and consolidates memories, and this is exacerbated with ageing. To understand changes in cellular composition that might underpin these age‐related developments, we have compared neurogenesis and the prevalence of immunofluorescently identified newly born and mature neurons, astrocytes and microglia in the dentate gyrus of mdx and wild‐type mice at 2, 4, 8 and 16 months of age. The number of adult‐born neurons was suppressed in the dentate gyrus subgranular zone of 2‐month‐old mdx mice. However, the numbers of granule cells and GABAA receptor, alpha 1‐expressing cells were similar in wild‐type and mdx mice at all ages. Strikingly, the numbers of astrocytes, particularly in the dentate gyrus molecular layer, were suppressed in mdx mice at all time points. Thus, dystrophin loss was associated with reduced hippocampal neurogenesis in early life but did not impact the prevalence of mature neurons across the lifespan of mdx mice. In contrast, normal age‐related dentate gyrus astrocyte proliferation was suppressed in dystrophic mice. Astrocytes are the most abundant cell type in the brain and are crucial in supporting neuronal function, such that loss of these cells is likely to contribute to hippocampal dysfunction reported in mdx mice.
- 10 January 2025
- Published by Wiley in Experimental Physiology
- Vol. 110 (4) , 585-598
Open AccessAstrocyte proliferation in the hippocampal dentate gyrus is suppressed across the lifespan of dystrophin‐deficient mdx mice
Absence of the structural protein, dystrophin, results in the neuromuscular disorder Duchenne Muscular Dystrophy (DMD). In addition to progressive skeletal muscle dysfunction, this multisystemic disorder can also result in cognitive deficits and behavioural changes that are likely to be consequences of dystrophin loss from central neurons and astrocytes. Dystrophin‐deficient mdx mice exhibit decreases in grey matter volume in the hippocampus, the brain region that encodes and consolidates memories, and this is exacerbated with ageing. To understand changes in cellular composition that might underpin these age‐related developments, we have compared neurogenesis and the prevalence of immunofluorescently identified newly born and mature neurons, astrocytes and microglia in the dentate gyrus of mdx and wild‐type mice at 2, 4, 8 and 16 months of age. The number of adult‐born neurons was suppressed in the dentate gyrus subgranular zone of 2‐month‐old mdx mice. However, the numbers of granule cells and GABAA receptor, alpha 1‐expressing cells were similar in wild‐type and mdx mice at all ages. Strikingly, the numbers of astrocytes, particularly in the dentate gyrus molecular layer, were suppressed in mdx mice at all time points. Thus, dystrophin loss was associated with reduced hippocampal neurogenesis in early life but did not impact the prevalence of mature neurons across the lifespan of mdx mice. In contrast, normal age‐related dentate gyrus astrocyte proliferation was suppressed in dystrophic mice. Astrocytes are the most abundant cell type in the brain and are crucial in supporting neuronal function, such that loss of these cells is likely to contribute to hippocampal dysfunction reported in mdx mice.
- Open Access
- 23 December 2024
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 43, 100935
Inhibition of hippocampal interleukin-6 receptor-evoked signalling normalises long-term potentiation in dystrophin-deficient mdx mice
- 23 December 2024
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 43, 100935
Open AccessInhibition of hippocampal interleukin-6 receptor-evoked signalling normalises long-term potentiation in dystrophin-deficient mdx mice
- 1 November 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327 (5) , G626-G628
Regional and conditional variability of FXR: new lessons on ileal inflammation and gut barrier functions
- 1 November 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327 (5) , G626-G628
Regional and conditional variability of FXR: new lessons on ileal inflammation and gut barrier functions
- Open Access
- 30 April 2022
- Published by Wiley in The Journal of Physiology
- Vol. 600 (11) , 2565-2578
Bile acids, bioactive signalling molecules in interoceptive gut‐to‐brain communication
Aside from facilitating solubilisation and absorption of dietary lipids and lipid‐soluble vitamins, amphipathic bile acids (BAs) also act as bioactive signalling molecules. A plethora of conjugated or unconjugated primary and bacterially modified secondary BA moieties have been identified, with significant divergence between species. These molecules are excreted into the external environment of the intestinal lumen, yet nuclear and membrane receptors that are sensitive to BAs are expressed internally in the liver, intestinal and neural tissues, amongst others. The diversity of BAs and receptors underpins the multitude of distinct bioactive functions attributed to BAs, but also hampers elucidation of the physiological mechanisms underpinning these actions. In this Topical Review, we have considered the potential of BAs as cross‐barrier signalling molecules that contribute to interoceptive pathways informing the central nervous system of environmental changes in the gut lumen. Activation of BAs on FGF19‐secreting enterocytes, enteroendocrine cells coupled to sensory nerves or intestinal immune cells would facilitate indirect signalling, whereas direct activation of BA receptors in the brain is likely to occur primarily under pathophysiological conditions when concentrations of BAs are elevated. image
- 30 April 2022
- Published by Wiley in The Journal of Physiology
- Vol. 600 (11) , 2565-2578
Open AccessBile acids, bioactive signalling molecules in interoceptive gut‐to‐brain communication
Aside from facilitating solubilisation and absorption of dietary lipids and lipid‐soluble vitamins, amphipathic bile acids (BAs) also act as bioactive signalling molecules. A plethora of conjugated or unconjugated primary and bacterially modified secondary BA moieties have been identified, with significant divergence between species. These molecules are excreted into the external environment of the intestinal lumen, yet nuclear and membrane receptors that are sensitive to BAs are expressed internally in the liver, intestinal and neural tissues, amongst others. The diversity of BAs and receptors underpins the multitude of distinct bioactive functions attributed to BAs, but also hampers elucidation of the physiological mechanisms underpinning these actions. In this Topical Review, we have considered the potential of BAs as cross‐barrier signalling molecules that contribute to interoceptive pathways informing the central nervous system of environmental changes in the gut lumen. Activation of BAs on FGF19‐secreting enterocytes, enteroendocrine cells coupled to sensory nerves or intestinal immune cells would facilitate indirect signalling, whereas direct activation of BA receptors in the brain is likely to occur primarily under pathophysiological conditions when concentrations of BAs are elevated. image
- Open Access
- 30 November 2021
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
Functional bowel disorders such as irritable bowel syndrome (IBS) are common, multifactorial and have a major impact on the quality of life of individuals diagnosed with the condition. Heterogeneity in symptom manifestation, which includes changes in bowel habit and visceral pain sensitivity, are an indication of the complexity of the underlying pathophysiology. It is accepted that dysfunctional gut-brain communication, which incorporates efferent and afferent branches of the peripheral nervous system, circulating endocrine hormones and local paracrine and neurocrine factors, such as host and microbially-derived signaling molecules, underpins symptom manifestation. This review will focus on the potential role of hepatic bile acids in modulating gut-to-brain signaling in IBS patients. Bile acids are amphipathic molecules synthesized in the liver, which facilitate digestion and absorption of dietary lipids. They are also important bioactive signaling molecules however, binding to bile acid receptors which are expressed on many different cell types. Bile acids have potent anti-microbial actions and thereby shape intestinal bacterial profiles. In turn, bacteria with bile salt hydrolase activity initiate the critical first step in transforming primary bile acids into secondary bile acids. Individuals with IBS are reported to have altered microbial profiles and modified bile acid pools. We have assessed the evidence to support a role for bile acids in the pathophysiology underlying the manifestation of IBS symptoms.
- 30 November 2021
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Open AccessAberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
Functional bowel disorders such as irritable bowel syndrome (IBS) are common, multifactorial and have a major impact on the quality of life of individuals diagnosed with the condition. Heterogeneity in symptom manifestation, which includes changes in bowel habit and visceral pain sensitivity, are an indication of the complexity of the underlying pathophysiology. It is accepted that dysfunctional gut-brain communication, which incorporates efferent and afferent branches of the peripheral nervous system, circulating endocrine hormones and local paracrine and neurocrine factors, such as host and microbially-derived signaling molecules, underpins symptom manifestation. This review will focus on the potential role of hepatic bile acids in modulating gut-to-brain signaling in IBS patients. Bile acids are amphipathic molecules synthesized in the liver, which facilitate digestion and absorption of dietary lipids. They are also important bioactive signaling molecules however, binding to bile acid receptors which are expressed on many different cell types. Bile acids have potent anti-microbial actions and thereby shape intestinal bacterial profiles. In turn, bacteria with bile salt hydrolase activity initiate the critical first step in transforming primary bile acids into secondary bile acids. Individuals with IBS are reported to have altered microbial profiles and modified bile acid pools. We have assessed the evidence to support a role for bile acids in the pathophysiology underlying the manifestation of IBS symptoms.
- Open Access
- 4 May 2021
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 33 (10) , e14160
Divergent effects of exendin‐4 and interleukin‐6 on rat colonic secretory and contractile activity are associated with changes in regional vagal afferent signaling
Background: The pro‐inflammatory cytokine, interleukin (IL)‐6 is elevated in individuals with the functional bowel disorder, irritable bowel syndrome (IBS). IL‐6 can independently modify intestinal secreto‐motor function, thereby contributing to IBS pathophysiology. Additionally, hormonal changes may underlie symptom flares. Post‐prandial exacerbation of IBS symptoms has been linked to secretion of the incretin hormone, glucagon‐like peptide‐1 (GLP‐1), which can also influence colonic secreto‐motor activity. This study aimed to ascertain if the effects of GLP‐1 on colonic secretory and contractile activity was impacted by elevated IL‐6 levels and if sensory signals regarding such changes were reflected in altered vagal afferent activity.Methods: Colonic secretory currents and circular muscle contractile activity was investigated in Sprague Dawley rats using Ussing chamber and organ bath electrophysiology. Regional afferent signaling was assessed using extracellular electrophysiological recordings from colonic vagal afferents.Key Results: Application of the GLP‐1 receptor agonist, exendin‐4 (Ex‐4) in the presence of IL‐6 potentiated colonic secretory currents and transepithelial resistance. Vagal afferent fibers originating in the submucosal layer exhibited larger responses to Ex‐4 when IL‐6 was also present. In contrast, co‐application of Ex‐4 and IL‐6 to gut‐bath chambers suppressed circular muscle contractile activity. The activity in extrinsic afferents originating in the colonic myenteric layer was similarly suppressed.Conclusions & Inferences: Application of Ex‐4 in the presence of IL‐6 had divergent modulatory effects on colonic secretion and contractile activity. Similar patterns were observed in vagal afferent signaling originating in the submucosal and myenteric neuronal layers, indicating regional afferent activity reflected immune‐ and endocrine‐mediated changes in colonic function.
- 4 May 2021
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 33 (10) , e14160
Open AccessDivergent effects of exendin‐4 and interleukin‐6 on rat colonic secretory and contractile activity are associated with changes in regional vagal afferent signaling
Background: The pro‐inflammatory cytokine, interleukin (IL)‐6 is elevated in individuals with the functional bowel disorder, irritable bowel syndrome (IBS). IL‐6 can independently modify intestinal secreto‐motor function, thereby contributing to IBS pathophysiology. Additionally, hormonal changes may underlie symptom flares. Post‐prandial exacerbation of IBS symptoms has been linked to secretion of the incretin hormone, glucagon‐like peptide‐1 (GLP‐1), which can also influence colonic secreto‐motor activity. This study aimed to ascertain if the effects of GLP‐1 on colonic secretory and contractile activity was impacted by elevated IL‐6 levels and if sensory signals regarding such changes were reflected in altered vagal afferent activity.Methods: Colonic secretory currents and circular muscle contractile activity was investigated in Sprague Dawley rats using Ussing chamber and organ bath electrophysiology. Regional afferent signaling was assessed using extracellular electrophysiological recordings from colonic vagal afferents.Key Results: Application of the GLP‐1 receptor agonist, exendin‐4 (Ex‐4) in the presence of IL‐6 potentiated colonic secretory currents and transepithelial resistance. Vagal afferent fibers originating in the submucosal layer exhibited larger responses to Ex‐4 when IL‐6 was also present. In contrast, co‐application of Ex‐4 and IL‐6 to gut‐bath chambers suppressed circular muscle contractile activity. The activity in extrinsic afferents originating in the colonic myenteric layer was similarly suppressed.Conclusions & Inferences: Application of Ex‐4 in the presence of IL‐6 had divergent modulatory effects on colonic secretion and contractile activity. Similar patterns were observed in vagal afferent signaling originating in the submucosal and myenteric neuronal layers, indicating regional afferent activity reflected immune‐ and endocrine‐mediated changes in colonic function.
- Open Access
- 15 May 2020
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 11, 436
Mucosal Tuft Cell Density Is Increased in Diarrhea-Predominant Irritable Bowel Syndrome Colonic Biopsies
Tuft cells are rare chemosensory sentinels found in the gut epithelium. When triggered by helminth infection, tuft cells secrete interleukin-25 (IL-25) basolaterally and subsequently evoke an immune response. Irritable bowel syndrome (IBS) is a common and heterogeneous disorder characterized by bowel dysfunction and visceral pain sensitivity. Dysfunctional gut-brain communication and immune activation contribute to the pathophysiology of this disorder. The study aims were to investigate changes in tuft cell density in non-post-infectious IBS patients. Immunofluorescent labeling of DCLK1-positive tuft cells was carried out in mucosal biopsies from the distal colons of diarrhea and constipation-predominant IBS patients and healthy controls. Tuft cell numbers were also assessed in animal models. Concentrations of interleukin-25 (IL-25) secreted from colonic biopsies and in plasma samples were analyzed using an immunoassay. The density of tuft cells was increased in diarrhea—but not constipation-predominant IBS patient colonic biopsies. Biopsy secretions and plasma concentrations of IL-25 were elevated in diarrhea—but not constipation-predominant IBS participants. Tuft cell hyperplasia was detected in a rat model of IBS but not in mice exposed to chronic stress. Tuft cell hyperplasia is an innate immune response to helminth exposure. However, the patients with diarrhea-predominant IBS have not reported any incidents of enteric infection. Moreover, rats exhibiting IBS-like symptoms displayed increased tuft cell density but were not exposed to helminths. Our findings suggest that factors other than helminth exposure or chronic stress lead to tuft cell hyperplasia in IBS colonic biopsies.
- 15 May 2020
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 11, 436
Open AccessMucosal Tuft Cell Density Is Increased in Diarrhea-Predominant Irritable Bowel Syndrome Colonic Biopsies
Tuft cells are rare chemosensory sentinels found in the gut epithelium. When triggered by helminth infection, tuft cells secrete interleukin-25 (IL-25) basolaterally and subsequently evoke an immune response. Irritable bowel syndrome (IBS) is a common and heterogeneous disorder characterized by bowel dysfunction and visceral pain sensitivity. Dysfunctional gut-brain communication and immune activation contribute to the pathophysiology of this disorder. The study aims were to investigate changes in tuft cell density in non-post-infectious IBS patients. Immunofluorescent labeling of DCLK1-positive tuft cells was carried out in mucosal biopsies from the distal colons of diarrhea and constipation-predominant IBS patients and healthy controls. Tuft cell numbers were also assessed in animal models. Concentrations of interleukin-25 (IL-25) secreted from colonic biopsies and in plasma samples were analyzed using an immunoassay. The density of tuft cells was increased in diarrhea—but not constipation-predominant IBS patient colonic biopsies. Biopsy secretions and plasma concentrations of IL-25 were elevated in diarrhea—but not constipation-predominant IBS participants. Tuft cell hyperplasia was detected in a rat model of IBS but not in mice exposed to chronic stress. Tuft cell hyperplasia is an innate immune response to helminth exposure. However, the patients with diarrhea-predominant IBS have not reported any incidents of enteric infection. Moreover, rats exhibiting IBS-like symptoms displayed increased tuft cell density but were not exposed to helminths. Our findings suggest that factors other than helminth exposure or chronic stress lead to tuft cell hyperplasia in IBS colonic biopsies.
- Open Access
- 30 April 2020
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 14, 95
Glucagon-Like Peptide-1 Secreting L-Cells Coupled to Sensory Nerves Translate Microbial Signals to the Host Rat Nervous System
An intact gut epithelium preserves the immunological exclusion of “non-self” entities in the external environment of the gut lumen. Nonetheless, information flows continuously across this interface, with the host immune, endocrine, and neural systems all involved in monitoring the luminal environment of the gut. Both pathogenic and commensal gastrointestinal (GI) bacteria can modulate centrally-regulated behaviors and brain neurochemistry and, although the vagus nerve has been implicated in the microbiota-gut-brain signaling axis, the cellular and molecular machinery that facilitates this communication is unclear. Studies were carried out in healthy Sprague–Dawley rats to understand cross-barrier communication in the absence of disease. A novel colonic-nerve electrophysiological technique was used to examine gut-to-brain vagal signaling by bacterial products. Calcium imaging and immunofluorescent labeling were used to explore the activation of colonic submucosal neurons by bacterial products. The findings demonstrate that the neuromodulatory molecule, glucagon-like peptide-1 (GLP-1), secreted by colonic enteroendocrine L-cells in response to the bacterial metabolite, indole, stimulated colonic vagal afferent activity. At a local level indole modified the sensitivity of submucosal neurons to GLP-1. These findings elucidate a cellular mechanism by which sensory L-cells act as cross-barrier signal transducers between microbial products in the gut lumen and the host peripheral nervous system.
- 30 April 2020
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 14, 95
Open AccessGlucagon-Like Peptide-1 Secreting L-Cells Coupled to Sensory Nerves Translate Microbial Signals to the Host Rat Nervous System
An intact gut epithelium preserves the immunological exclusion of “non-self” entities in the external environment of the gut lumen. Nonetheless, information flows continuously across this interface, with the host immune, endocrine, and neural systems all involved in monitoring the luminal environment of the gut. Both pathogenic and commensal gastrointestinal (GI) bacteria can modulate centrally-regulated behaviors and brain neurochemistry and, although the vagus nerve has been implicated in the microbiota-gut-brain signaling axis, the cellular and molecular machinery that facilitates this communication is unclear. Studies were carried out in healthy Sprague–Dawley rats to understand cross-barrier communication in the absence of disease. A novel colonic-nerve electrophysiological technique was used to examine gut-to-brain vagal signaling by bacterial products. Calcium imaging and immunofluorescent labeling were used to explore the activation of colonic submucosal neurons by bacterial products. The findings demonstrate that the neuromodulatory molecule, glucagon-like peptide-1 (GLP-1), secreted by colonic enteroendocrine L-cells in response to the bacterial metabolite, indole, stimulated colonic vagal afferent activity. At a local level indole modified the sensitivity of submucosal neurons to GLP-1. These findings elucidate a cellular mechanism by which sensory L-cells act as cross-barrier signal transducers between microbial products in the gut lumen and the host peripheral nervous system.